NewsBenzingaLadenburg Thalmann avvia la copertura su Nutex Health con rating Buy, annuncia un target di prezzo di 336 dollari Ladenburg Thalmann avvia la copertura su Nutex Health con rating Buy, annuncia un target di prezzo di 336 dollari Benzinga 2026.10.26 16:26 (GMT+0) Open on Benzinga Other news Anthropic IPO Filing Reveals AI Boom’s Next Test: 7 ETFs With Pre-Launch Exposure It's Too Soon To Upgrade Stryker Corporation (NYSE:SYK) UBS Maintains Neutral on Fluence Energy, Lowers Price Target to $6 Housing Affordability Crisis: Mortgage Payments Have Nearly Doubled Since 2020 UBS Maintains Neutral on Wendy's, Lowers Price Target to $6.5 Blackmail, Self-Preservation, and Politics: 3 Unusual Risks That Cloud Anthropic’s IPO
